Stock Analysis
- Japan
- /
- Healthcare Services
- /
- TSE:6197
Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality
Soft earnings didn't appear to concern Solasto Corporation's (TSE:6197) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.
See our latest analysis for Solasto
The Impact Of Unusual Items On Profit
For anyone who wants to understand Solasto's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by JP¥3.9b due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. In the twelve months to September 2024, Solasto had a big unusual items expense. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Solasto's Profit Performance
As we mentioned previously, the Solasto's profit was hampered by unusual items in the last year. Because of this, we think Solasto's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! On the other hand, its EPS actually shrunk in the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. To that end, you should learn about the 4 warning signs we've spotted with Solasto (including 1 which is concerning).
Today we've zoomed in on a single data point to better understand the nature of Solasto's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:6197
Solasto
Provides medical outsourcing services to medical institutions in Japan.